CliffBio
small molecule

CORLANOR

IVABRADINE HYDROCHLORIDE

Loss of exclusivityJune 2027latest FDA-listed patent expiry
CompanyAmgen →See this company's full patent-cliff portfolio

Drug detail

Brand nameCORLANOR
Active ingredientIVABRADINE HYDROCHLORIDE
StrengthEQ 7.5MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalApril 2015
Marketing statusDISCN

Listed patents

PatentExpiresType
7867996*PEDJune 2027—
7867996December 2026substance, product
7361649*PEDAugust 2026—
7879842*PEDAugust 2026—
7361650*PEDAugust 2026—
7879842February 2026substance, product
7361650February 2026substance, product
7361649February 2026substance, product

More from Amgen

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.